Compare · HUM vs NEUE
HUM vs NEUE
Side-by-side comparison of Humana Inc. (HUM) and NeueHealth Inc. (NEUE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HUM and NEUE operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM carries a market cap of $42.74B.
- Over the past year, HUM is up 52.7% and NEUE is down 1.2% - HUM leads by 54.0 points.
- HUM has hit the wire 4 times in the past 4 weeks while NEUE has been quiet.
- HUM has more recent analyst coverage (25 ratings vs 0 for NEUE).
- Company
- Humana Inc.
- NeueHealth Inc.
- Price
- $355.91+1.64%
- $6.84+2.09%
- Market cap
- $42.74B
- -
- 1M return
- +43.90%
- +2.09%
- 1Y return
- +52.72%
- -1.23%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 4
- 0
- Recent ratings
- 25
- 0
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest HUM
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
- Humana upgraded by Deutsche Bank with a new price target
- Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness
- Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana
- Chief Financial Officer Mellet Celeste gave a grant of 15,387 units of Humana Common, decreasing direct ownership by 28% to 39,637 units (SEC Form 4)
- Chief Information Officer Mehta Japan was granted 9,448 units of Humana Common, increasing direct ownership by 122% to 17,176 units (SEC Form 4)
- President, Enterprise Growth Dintenfass David was granted 11,273 units of Humana Common, increasing direct ownership by 80% to 25,407 units (SEC Form 4)
- President & CEO Rechtin James A. was granted 35,633 units of Humana Common (SEC Form 4)
Latest NEUE
- Chief Financial Officer Matushak Jay returned 40,431 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 15-12G filed by NeueHealth Inc.
- Large owner Bessemer Venture Partners Ix L.P. returned 999,218 shares to the company (SEC Form 4)
- Director Kraus Stephen returned 16,443 shares to the company, closing all direct ownership in the company (SEC Form 4)
- GC & Corporate Secretary Craig Jeffery Michael returned 20,103 shares to the company, closing all direct ownership in the company (SEC Form 4)
- EVP, Consumer Care Orozco Tomas returned 29,325 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Sheehy Robert J returned 265,945 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Adkins Kedrick D Jr returned 16,443 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Kadre Manuel returned 33,505 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Slavitt Andrew M returned 107,809 shares to the company, closing all direct ownership in the company (SEC Form 4)